Medfield Diagnostics

What Medfield Diagnostics does

Medfield Diagnostics is a Swedish medical technology company headquartered in Göteborg, Sweden, founded in 2005. According to its self-description, the company provides diagnostic capabilities using microwave technology, positioning its offerings as a safer alternative to conventional diagnostic modalities. The company is small, with between 11 and 50 employees, and operates as a privately held for-profit entity. Its founders, Mikael Persson and Andreas Fhager, are associated with microwave engineering and applied physics research, consistent with the technical foundations of microwave-based diagnostic instrumentation. The company is led by CEO Stefan Blomsterberg.

No detailed product catalog, pricing model, customer list, or specific clinical indication is disclosed in the available sources; the company website was inaccessible at the time of data collection, displaying only a verification page. The most recent dated activity is participation in the Propel@YH accelerator program in January 2024, which provides UK NHS-aligned market validation pathways, and a small 2019 EISMEA grant of approximately $81,868, indicating a profile of grant-supported and accelerator-validated early-stage development rather than scaled commercial sales. The addressable market context is the global stroke diagnostic and therapeutic market, projected at USD 42.07 billion in 2025 and expanding to USD 83.91 billion by 2034, within which Medfield's microwave-based approach would compete.

Given the data gaps — including absence of disclosed revenue, pricing, partnerships, named customers, product specifications, and a recent operating history beyond accelerator participation — Medfield Diagnostics appears to be an early-stage, R&D-focused medtech venture whose commercial maturity is not yet observable from public sources. Capital formation to date has been limited and predominantly non-dilutive, consistent with a pre-commercial or pilot-stage business model.

Name

Medfield Diagnostics

Website

https://medfielddiagnostics.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Short description

Medfield Diagnostics is a Swedish medtech company founded in 2005 that develops microwave-based diagnostic devices aimed at safer clinical diagnostics, serving healthcare providers as its end market while operating at an early pre-commercial stage.

Ownership category

akta.pro rank

Product category

Medical Diagnostics Equipment

NAICS

Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Remote Diagnostics & Home Testing Devices (Connected POC/At-Home Diagnostic Readers) (HLAHACAL)

akta.pro secondary industries

Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Medical Imaging AI (HDAAAEAH)

Keywords

• Microwave diagnostics
• Stroke diagnostics
• Medical imaging devices
• Non-invasive diagnostics
• Brain diagnostics equipment

Headquarters

HQ city

Göteborg

HQ country

Sweden

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Supply Chain

Core offering

Medfield Diagnostics develops and supplies diagnostic devices that use microwave technology to enable safer medical diagnostics, with the company's positioning aligned to neurological and stroke-related diagnostic applications. The company offers a hardware-based diagnostic platform targeting healthcare providers such as hospitals and specialist units.

Differentiator

Problem solved

Functional benefit

Products and services

• Microwave-based diagnostic device (Medfield diagnostic platform) Diagnostic hardware leveraging proprietary microwave technology intended to enable safer medical diagnostics, with application context pointing to neurological/stroke-related diagnostic use in hospitals and specialist clinical units.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves3 records

Expansion highlights4 records

Broad incumbents

• Compumedics: Established neurology diagnostics and sleep-monitoring device company. Comparable as a neurology-focused medtech with hardware-plus-software brain diagnostics, though broader in scope than Medfield's microwave platform.
• Masimo: Global patient monitoring and non-invasive sensor company with broad hospital footprint. Comparable as an incumbent non-invasive acute-care monitoring vendor that competes for hospital connectivity and POC workflows.
• GE HealthCare: Global imaging and ultrasound OEM dominating CT/MRI-based stroke workflow. Comparable as the incumbent whose installed base defines the clinical pathway Medfield's microwave device would need to integrate with or disrupt.
• Siemens Healthineers: Large imaging and point-of-care diagnostics vendor with significant neurology and stroke imaging presence. Comparable incumbent across both diagnostic imaging and emerging POC/AI triage applications.
• Philips Healthcare: Broad medtech incumbent in imaging, patient monitoring, and emergency care. Comparable as the type of global OEM that could either partner with or outpace a small microwave-diagnostics startup.
• Nihon Kohden: Major patient monitoring and neurology diagnostics OEM with global installed base in emergency and ICU settings. Comparable as an established brain/neurology monitoring incumbent whose distribution Medfield would need to access or compete against.

Direct peers

• Infrascan: Maker of the Infrascanner, a near-infrared handheld device for detecting intracranial hematomas at point of care. Closely comparable portable brain-diagnostic device targeting the same pre-hospital / emergency triage workflow.
• Nova Biomedical: Manufacturer of point-of-care diagnostic instruments (blood gas, chemistry, critical care analyzers). Comparable as a POC medical-device vendor with proprietary hardware plus consumables economics in acute settings.
• BrainScope: Develops handheld, non-invasive brain-injury assessment devices using EEG and algorithmic signal analysis at point of care. Directly comparable to Medfield's portable, non-invasive brain-diagnostic concept for acute care settings.

Emerging players

• Cumulus Neuroscience: Emerging player building digital biomarker and brain-monitoring platforms for neurology clinical trials. Comparable as a non-invasive brain-signal diagnostics company, though more software/clinical-trial oriented than Medfield's hardware-led approach.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medfield Diagnostics